Sivan Innovation is a brand that offers the first clinically proven platform for the early detection of disease and relapse. They aim to solve the frustrating problem of discovering health issues too late for effective treatment and the disappointment patients face when little can be done for them. With a multidisciplinary team of clinicians, technologists, and behavioral experts, Sivan has developed a radical new approach to capturing and processing patient reported outcomes (PRO).

Drawing on extensive clinical studies conducted by leading oncologists in the US and France, Sivan has created the first digital platform for early disease detection. Their flagship product, Moovcare®, has been warmly received by patients for its ease of use, short questionnaire response time, and constant connection with the medical team. Sivan's future plans include collaborating with oncologists to develop other breakthrough digital therapeutics to monitor symptoms and detect relapse, complications, or future medical risks.

Sivan Innovation is on a mission to improve patient survival and revolutionize cancer care